Pitch Engine

Times Advertising


.

Why Headless CMS Is Critical for Cross-Border Brand Consistency: Building One Global Voice Across Many Markets

The larger a brand grows, the easier it becomes to jeopardize consistent communications. Brand experiences are impacted across different languages, cultures, legalities and marketing strat...

Using Structured Content to Build Multi-Step Marketing Funnels: A Scalable Framework for Guided Conversion

Multi-step marketing funnels aim to take users from awareness to conversion and through subsequent stages. Where basic funnels capture all momentum on one landing page, modern marketing ef...

From Pages to Components: How Headless CMS Changes Content Strategy

For years, content strategy was all about pages. Websites were created, written, designed, and optimized one by one, with content closely connected to placement and presentation. It made s...

Supporting Real-Time Interfaces with API-First Content Systems

Real-time interfaces have changed user expectations across many digital solutions. From live data dashboards to conversational interfaces and collaborative platforms, in-app alerts and con...

Biosafety Cabinet vs Ductless Fume Hood: Engineering Safety in Modern Laboratories

Why Containment Equipment Defines Research Integrity The modern laboratory is an environment of controlled risks. Whether handling infectious microorganisms or volatile organic solvents, ...

How Small Businesses Can Compete With Big Brands In Media Coverage?

Corporations with massive marketing expenditures are no longer the sole beneficiaries of media exposure in the contemporary digital era. Small businesses now have access to tools, platforms...

香港 - Media OutReach - 2022年12月12日 - 近日，上海市和武汉市有关部门制定了"止咳、退热、抗病毒、抗菌素"四类药品目录，共计174款药品。其中，石四药集团有限公司（「石四药集团」；股份代号：2005.HK）众多产品被纳入此次的疫情防护家庭常备药品目录中，包括：抗病毒药物盐酸阿比多尔胶囊，抗菌药阿奇霉素分散片、阿奇霉素干混悬剂、阿奇霉素片、头孢地尼胶囊、头孢克洛干混悬剂，中成药银黄胶囊等。 12月10日上海瑞金医院发布"阿比多尔对于奥密克戎的前瞻、开放、对照研究"，研究资料证实：阿比多尔对于奥密克戎安全有效，门急诊口服给药，方便经济。阿比多尔可有效改善低淋巴细胞血症，在抗病毒过程中具有免疫调节作用。华中科技大学附属同济医院呼吸内科主任刘辉国也表示，冬季呼吸道疾病高发，流感和新冠均不容忽视，并推荐了阿比多尔等抗病毒药，以及解热镇痛药、止咳化痰药、抗生素药等多款药物作为家庭常备药。 石四药集团的阿比多尔于2006年被批准上市，获批适应症为甲型、乙型流感病毒引起的上呼吸道感染。国内抗疫新形势下，需求量猛增，处于供不应求状态。石四药集团是中国最大的阿比多尔原料药和胶囊制剂生产商，同时也是国内阿奇霉素原料药和各类制剂的重要生产商。预期阿比多尔和阿奇霉素将为石四药集团的未来带来突破性增长。 Hashtag: #石四药

The issuer is solely responsible for the content of this announcement.

关于石四药集团有限公司

石四药集团有限公司是中国领先的制药商之一，拥有超过七十年营运历史及知名品牌。本集团于 2005 年 12 月于香港联合交易所上市，股份代号为 2005。本集团主要从事研究、开发、制造及销售广泛类别药物产品，包括向医院及分销商销售主要为静脉输液及安瓿注射液的成药、原料药及医用材料。集团的制造厂房位于中国河北省及江苏省，其药物产品于中国高端医院市场处领先地位。

Source https://www.media-outreach.com/news/hong-kong/2022/12/12/185839/